Pfizer ups profit view, sees more late-stage drugs
319654
NEW YORK/GROTON, Connecticut  - Pfizer Inc.  raised its 2006 profit forecast on Thursday and said its roster of experimental drugs in late-stage testing could triple by 2009.
417741
Pfizer Inc. PFE.N on Wednesday said  third-quarter earnings rose on higher sales of cholesterol and  arthritis drugs, but the company cautioned that 2005 results  will likely be hurt by generic competition for four other  popular medicines.
668144
Johnson &amp; Johnson, which makes products ranging from heart stents to Band-Aids, said third- quarter profit rose 13 percent on higher sales of drugs used to treat rheumatoid arthritis and schizophrenia.
692786
NEW YORK - Pfizer Inc. said Wednesday that third quarter earnings, excluding charges, beat Wall Street expectations by a penny, on strong sales of Lipitor and Celebrex medicines.
545098
Swiss pharmaceutical giant Roche reported Wednesday a better-than-expected 2007 net profit of 11.4 billion Swiss francs (10.4 billion dollars, 7.1 billion euros), boosted by cancer drug sales.
331670
Medco Health Solutions Inc  on Tuesday posted higher-than-expected quarterly earnings, helped by sales of generic drugs, and the pharmacy benefit manager boosted its full-year profit forecast.
378273
The health care products maker posted higher profit in the fourth quarter versus year-earlier results that were reduced by acquisition charges for Kos Pharmaceuticals.
446695
Merck & Co. on Monday said  second-quarter earnings rose on higher sales of its new  vaccines and medicines, and the company raised its 2007 profit  forecast amid continuing strong demand for the medicines.
448727
Pharmaceutical group Sanofi-Synthelabo said it had increased net profit in the first half of the year by 20.6 percent from the same period last year to 1.138 billion euros (1.38 billion dollars).
111721
Pfizer Inc. PFE.N , the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose, helped by strong sales of cholesterol treatment Lipitor  and arthritis drug Celebrex.
272056
The Swiss pharmaceuticals giant Roche, manufacturer of anti-flu drug Tamiflu, said its first-half net profit had increased by 37 percent to 4.54 billion Swiss francs (2.9 billion euros, 3.62 billion dollars).
636969
Abbott Laboratories Inc. ABT.N on  Tuesday said its fourth-quarter profit rose 3.2 percent on  higher sales of its prescription drugs, including its popular  new treatment for rheumatoid arthritis, Humira.
511457
Pfizer Inc. PFE.N, the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose on strong sales of cholesterol treatment Lipitor and  arthritis drug Celebrex.
574939
Pfizer Inc , the world's biggest drugmaker, on Wednesday reported fourth-quarter results that beat expectations.
161285
Walgreen Co.  on Monday said  quarterly profit rose 14.2 percent, aided by higher sales of  prescription medications, and said it would look at more  acquisitions as the drugstore industry consolidates.
54905
Pfizer Inc. PFE.N on Tuesday  reaffirmed it expects 2004 earnings to be more than 20 percent  above last year, but warned that results in 2005-2007 will be  hurt by patent expirations on over a half-dozen of its  best-selling medicines.
736352
Pfizer Inc.  on Wednesday said third-quarter earnings rose on higher sales of cholesterol and arthritis drugs, but the company cautioned that 2005 results will likely be hurt by generic competition for four other popular medicines.